Muscle hypotonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
967
|
579
|
0.100 |
None |
1.000 |
11 |
1
|
2008 |
2017 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.100 |
None |
1.000 |
11 |
1
|
2008 |
2017 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.590 |
None |
1.000 |
11 |
1
|
2010 |
2018 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
5
|
0.590 |
None |
1.000 |
9 |
1
|
2013 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.090 |
None |
1.000 |
9 |
|
2013 |
2019 |
Chronic Neutrophilic Leukemia
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
16
|
4
|
0.080 |
None |
1.000 |
8 |
|
2013 |
2018 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.570 |
None |
1.000 |
8 |
2
|
2013 |
2018 |
Leukemia, Myelomonocytic, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
158
|
28
|
0.080 |
None |
1.000 |
8 |
|
2013 |
2019 |
Toxic Shock Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
61
|
|
0.060 |
None |
1.000 |
6 |
|
1995 |
2019 |
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
179
|
70
|
0.550 |
None |
1.000 |
6 |
1
|
2013 |
2017 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2019 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.050 |
None |
1.000 |
5 |
|
2015 |
2018 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29
|
disease |
|
Disease or Syndrome
|
1
|
8
|
0.400 |
None |
1.000 |
5 |
8
|
2010 |
2017 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
751
|
232
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2019 |
Staphylococcal toxic shock syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
28
|
|
0.050 |
None |
1.000 |
5 |
|
1995 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2013 |
2017 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2019 |
Monosomy
|
group |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
214
|
11
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2017 |
Isochromosomes
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
75
|
2
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2016 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Profound Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
160
|
3
|
0.300 |
None |
1.000 |
2 |
|
2010 |
2014 |
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2019 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Language Development Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
18
|
|
0.310 |
None |
1.000 |
2 |
|
2014 |
2016 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
1.000 |
2 |
2
|
2015 |
2017 |